UCB’s Bimzelx Impresses In Psoriatic Arthritis Amid US Psoriasis Approval Delay

UCB Celebrates Win In Psoriatic Arthritis Even As Regulatory Wait Is Prolonged • Source: Alamy

More from Clinical Trials

More from R&D